BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: NMDA receptor NR1 subtype (GRIN1; NR1)

August 25, 2016 7:00 AM UTC

In vitro and mouse studies suggest antagonizing GRIN1 could help treat MS. In an in vitro assay of inflammation-associated blood-brain barrier (BBB) permeability, an anti-GRIN1 mAb decreased monocyte ...